3/A

PRIMARY DOCUMENT

Company: LIGAND PHARMACEUTICALS INC
Filed: October 19, 2006
Period of Report: September 27, 2006
Accession Number: 0000886163-06-000120

View Document ↗ View on SEC.gov ↗